Alere Inc operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alere Inc with three other
pharmaceutical manufacturers in North America:
Alexion Pharmaceuticals, Inc.
sales of $2.60 billion
of which 100%
was Therapeutic Products),
Dr.Reddy's Laboratories Ltd
of which 81%
was Generics), and
of which 62%
was Oral Technologies).
During the year ended December of 2015, sales at
Alere Inc were $2.46 billion.
decrease of 4.8%
versus 2014, when the company's sales were $2.59 billion.
Contributing to the drop in overall sales was the 22.6% decline
in Consumer Diagnostic Products, from $109.96 million to $85.13 million.
However, these declines were partially offset by the increase in sales of
Professional Diagnostics (up 1.6% to $2.38 billion)